A Imagawa
Overview
Explore the profile of A Imagawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lewis A, Beresford A, Chambers M, Clark G, Hartley D, Hirst K, et al.
Bioorg Med Chem Lett
. 2020 Sep;
30(22):127536.
PMID: 32898695
The identification and SAR development of a series of negative allosteric modulators of the GABA α5 receptor is described. This novel series of compounds was optimised to provide analogues with...
2.
3.
Kakushima N, Hori K, Ono H, Horimatsu T, Uedo N, Ohata K, et al.
J Gastroenterol
. 2015 May;
51(2):104-11.
PMID: 25940151
Background: Whether proton pump inhibitors (PPIs) relieve heartburn or precordial pain after endoscopic resection (ER) for esophageal squamous cell carcinoma (ESCC) remains unclear. The aim of this study was to...
4.
Fujisawa R, Haseda F, Tsutsumi C, Hiromine Y, Noso S, Kawabata Y, et al.
Clin Exp Immunol
. 2015 Feb;
180(3):452-7.
PMID: 25682896
Programmed cell death-1 (PD-1) is a co-stimulatory molecule that inhibits T cell proliferation. We aimed to clarify PD-1 expression in CD4(+) T cells and the association between PD-1 expression and...
5.
Haseda F, Imagawa A, Murase-Mishiba Y, Terasaki J, Hanafusa T
Clin Exp Immunol
. 2013 Apr;
173(2):207-16.
PMID: 23607886
Accumulating lines of evidence have suggested that regulatory T cells (T(regs)) play a central role in T cell-mediated immune response and the development of type 1A and fulminant type 1...
6.
Yoneda S, Uno S, Iwahashi H, Fujita Y, Yoshikawa A, Kozawa J, et al.
J Clin Endocrinol Metab
. 2013 Mar;
98(5):2053-61.
PMID: 23539729
Context: A decrease in pancreatic β-cell mass is involved in the development of type 2 diabetes. Objective: The purpose of this study was to evaluate the β-cell mass and the...
7.
Ishii M, Sakairi Y, Hara H, Imagawa A, Shimizu S, Takahashi J, et al.
Neurol Sci
. 2011 Aug;
33(2):453-61.
PMID: 21822697
Moderate to severe migraine attacks are treated with triptans. However, about 25% of migraineurs fail to respond to triptans. We investigated the involvement of gene polymorphisms, personality traits and characteristics...
8.
Inomata-Kurashiki Y, Maeda K, Yoshioka E, Fukuhara A, Imagawa A, Otsuki M, et al.
Horm Metab Res
. 2010 Mar;
42(5):318-23.
PMID: 20221981
To treat metabolic syndrome, fat tissue dysfunction should be corrected rather than controlling conventional risk factors such as hypertension, dyslipidemia, and diabetes mellitus. For this purpose, accumulating evidence suggests increasing...
9.
Kawabata Y, Ikegami H, Awata T, Imagawa A, Maruyama T, Kawasaki E, et al.
Diabetologia
. 2009 Oct;
52(12):2513-21.
PMID: 19812988
Aim/hypothesis: We sought to clarify similarities and differences in the contribution of HLA to genetic susceptibility to three subtypes of type 1 diabetes: acute-onset, fulminant and slowly progressive. Methods: We...
10.
Imagawa A, Hanafusa T
Diabetologia
. 2009 Sep;
52(11):2464-2465.
PMID: 19727659
No abstract available.